Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAcid reflux is one of the more frequently reported digestive side effects of tirzepatide, and it tends to peak in the first few weeks after starting or increasing your dose. The good news, backed by NHS guidance on tirzepatide, is that most people find it manageable with a few straightforward adjustments to how and when they eat. Mounjaro slows the rate at which food leaves your stomach — a deliberate part of how it reduces appetite — and that same mechanism can allow stomach acid to sit closer to the oesophagus for longer than usual. Understanding the cause makes the practical fixes much easier to follow. These are prescription-only medicines, and any persistent or severe symptoms should always be discussed with your prescriber, who can assess whether a temporary dose pause or other support is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clinical evidence is clear about the mechanism. Tirzepatide activates GIP and GLP-1 receptors, and one downstream effect is a significant slowing of gastric emptying, food moves through your stomach more slowly, which is part of why appetite falls and blood sugar stabilises. The NHS patient information for tirzepatide lists indigestion, reflux and burping among the common side effects, and this is the reason why. When digestion is slowed, stomach contents (including acid) spend longer in the upper digestive tract, and the lower oesophageal sphincter comes under greater pressure. The result is that familiar burning sensation rising from the chest.
This effect is dose-dependent. Many people notice it most sharply after moving up to a higher strength (5mg, 7.5mg, or beyond) and then find it fades over the following fortnight as their system adjusts. That adjustment pattern is consistent with what prescribers observe across the wider picture of Mounjaro side effects. It does not mean the medicine is harming you; it means your gut is recalibrating. That said, recalibrating is uncomfortable, and it is worth taking it seriously from the start rather than waiting to see how bad it gets.
One thing worth noting: the night-time pattern of reflux on Mounjaro can be slightly different, because lying flat removes gravity's help in keeping acid down. Evening meals and bedtime habits matter more than you might expect.
Evidence from gastroenterology and practical NHS guidance converges on a short list of changes that reduce reflux risk during slowed gastric emptying. Portion size is probably the single biggest lever. When your stomach empties slowly and you add a large meal on top, the pressure and acid exposure both increase. Eating roughly half what you might have eaten before treatment (slowly, sitting upright) can make a significant difference within days.
Fatty and fried foods delay gastric emptying further on top of what tirzepatide is already doing; they also relax the lower oesophageal sphincter, the ring of muscle that keeps acid from moving upward. Reducing them during dose-increase weeks is a practical first step. The same applies to fizzy drinks, citrus juices, strong coffee and alcohol, all of which are documented triggers for reflux independent of any medication.
Timing matters too. Leaving at least two to three hours between your last meal and lying down gives your stomach more time to do its work before gravity is removed from the equation. If your injection day falls on a day when routine is disrupted (a bank holiday, a long weekend away, the kind of week where meals happen at odd hours) building in that gap consciously is worth the effort. Many people find this one change produces a noticeable improvement.
For more on how tirzepatide causes acid reflux and what the evidence says about managing it, our detailed explainer covers the physiology in full.
Most reflux on Mounjaro is mild to moderate and resolves without medical intervention beyond the dietary adjustments above. The NHS recommends keeping your prescriber informed about any persistent digestive symptoms, because there are clinical options available, including whether your dose titration pace needs adjusting, or whether an over-the-counter antacid or proton pump inhibitor is appropriate alongside your treatment.
There are symptoms that should prompt you to seek medical help promptly rather than managing things yourself. Severe or unrelenting chest pain needs urgent assessment to rule out cardiac causes. Difficulty swallowing, or a sensation that food is sticking, warrants a GP call. Blood in vomit or very dark stools are signs to seek help the same day. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is also the right place to report any suspected side effect that feels serious or unexpected.
Reflux that continues beyond four weeks at a stable dose, or that worsens rather than improves, is also worth raising, your prescriber may consider whether a longer stay at the current dose before the next increase would help. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is approved, so there is always a clinical conversation available if something is troubling you. That review is not a formality.
If you are weighing up the broader experience of being on Mounjaro, including both the benefits and the side effects, our full Mounjaro overview covers what to expect across the treatment.
Beyond diet, a few behavioural changes are consistently cited in NHS guidance on managing reflux. Elevating the head of the bed by around 20cm (using a wedge pillow or raising the bed frame, not just adding another regular pillow) keeps the oesophagus above the stomach through the night and can produce a noticeable improvement in morning symptoms. Loose, comfortable clothing around the waist reduces abdominal pressure, which is a smaller but real factor when gastric emptying is slowed.
Smoking worsens reflux by relaxing the lower oesophageal sphincter and reducing saliva production; if you smoke, this is an additional reason to address it alongside treatment. Weight loss itself, over the longer term, generally reduces reflux because abdominal fat exerts direct pressure on the stomach, so treatment that works tends to improve this side effect over time even as it is more noticeable at the start.
For questions about whether Mounjaro is the direct cause of your reflux or whether something else might be contributing, that page looks at the distinction carefully. And if digestive symptoms beyond reflux are a concern, the explanation of how long diarrhoea typically lasts on Mounjaro follows the same evidence-led approach.
If you have not yet started treatment and want to discuss your medical history, including any existing reflux or gastrointestinal conditions, with a prescriber before committing, you can start a free consultation with our team today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.